Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine burst infusions for chronic refractory pain
ACTRN12622001305718Phase 4Recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ketamine in chronic pain, sponsored by Prince of Wales Hospital. Primary endpoint: Long-term analgesic effect. Started Aug 2022; status: recruiting.
02
Drugs
ketamine
03
Conditions
chronic pain
Beyond the preview
Go deeper on ACTRN12622001305718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001305718.